Genaxxon bioscience GmbH appoints Dr. Iris Steitz as Chief Product & Marketing Officer (CPMO)

We are pleased to announce that Dr. Iris Steitz has been appointed Chief Product & Marketing Officer (CPMO). In this newly expanded leadership role, Dr. Iris Steitz will be responsible for aligning product management and marketing even more closely, strengthening the connection between innovation, market positioning, and sustainable company growth.

Since joining Genaxxon three years ago as Product Manager, Dr. Iris Steitz has played a key role in shaping and continuously developing the company’s product portfolio. With a strong focus on customer needs, market trends, and scientific excellence, Dr. Iris Steitz quickly expanded responsibilities beyond product management and became increasingly involved in strategic marketing initiatives.

Through this close connection between product development and market communication, Dr. Iris Steitz has significantly contributed to strengthening Genaxxon’s market presence and sharpening the positioning of its portfolio across key areas such as PCR, qPCR, RT-qPCR, and molecular biology solutions.

In the role of CPMO, Dr. Iris Steitz will lead the strategic integration of product and marketing activities, with a focus on accelerating innovation, identifying new market opportunities, and ensuring that product development and customer communication remain closely aligned.

“Over the past three years, Iris Steitz has made a remarkable impact on both our product strategy and our market approach,” says Dr. Norbert Tröndle, CEO of Genaxxon. “The way Iris Steitz combines strategic thinking, customer understanding, and a strong drive for innovation made this next step a natural decision for us. Bringing product and marketing together under one leadership reflects exactly where we want to go as a company.”

For Dr. Iris Steitz, the new role represents both a continuation of the journey so far and an opportunity to shape the company’s future even more actively.

“From the beginning, my focus has always been on building a product portfolio that create real value for our customers,” says Dr. Iris Steitz. “Over time, it became clear that product success and strong market communication go hand in hand. I’m excited to take on this new role and continue connecting innovation, strategy, and customer needs even more closely.”

With this appointment, Genaxxon underlines its commitment to a product-driven growth strategy, where scientific excellence, customer proximity, and clear market positioning form the foundation for long-term success.